Presenilin-directed inhibitors of γ-secretase trigger caspase 3 activation in presenilin-expressing and presenilin-deficient cells

被引:7
作者
da Costa, CA
Ayral, E
Hernandez, JF
St George-Hyslop, P
Checler, F
机构
[1] CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France
[2] LAPP, CNRS, UMR 5810, Montpellier, France
关键词
caspase; 3; gamma-secretase; inhibitors; presenilins; presenilins-knockout;
D O I
10.1111/j.1471-4159.2004.02512.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid beta peptide (Abeta) is generated by subsequent cleavages by beta- and gamma-secretases. Therefore, these two enzymes are putative therapeutic targets to prevent Abeta production, and hopefully to slow down or even stop the Alzheimer's disease (AD) neurodegenerative process. Several studies have revealed that gamma-secretase hydrolyses other important substrates besides beta-amyloid precursor protein (betaAPP) thus adding another level of complexity to designing fully AD-specific interfering drugs. Here we demonstrate that three distinct presenilin-directed gamma-secretase inhibitors as well as JLK compounds indirectly potentiate caspase 3 activity, the effector caspase of the apoptotic cascade. Thus, inhibitors were shown to drastically stimulate caspase 3 activity in wild-type mice blastocyst-derived and fibroblast cells. Interestingly, some of these inhibitors known to interact with presenilins also trigger caspase activation in presenilin-deficient cells. However, inhibitors do not affect recombinant caspase 3 activity, indicating that the effect on this enzyme was indirect. Furthermore, we established that caspase 3 activation was not due to an effect of gamma-secretase inhibitors on calpains, a family of proteolytic enzymes able to modulate caspase 3 activity. Altogether, our data demonstrate that presenilin-directed gamma-secretase inhibitors affect caspase 3 activity in a presenilin-independent manner. Therefore, as presenilin-dependent gamma-secretase activity is not specific for betaAPP and because its inhibitors clearly affect other vital cell functions, care should be taken in considering 'gamma-secretase' inhibitors as putative therapeutic tools to interfere with AD pathology.
引用
收藏
页码:800 / 806
页数:7
相关论文
共 57 条
[1]  
ARAKI W, 2000, CURR T BIOCHEM RES, V3, P157
[2]   Endogenous β-amyloid production in presenilin-deficient embryonic mouse fibroblasts [J].
Armogida, M ;
Petit, A ;
Vincent, B ;
Scarzello, S ;
da Costa, CA ;
Checler, F .
NATURE CELL BIOLOGY, 2001, 3 (11) :1030-1033
[3]   Pharmacological knock-down of the presenilin 1 heterodimer by a novel γ-secretase inhibitor -: Implications for presenilin biology [J].
Beher, D ;
Wrigley, JDJ ;
Nadin, A ;
Evin, G ;
Masters, CL ;
Harrison, T ;
Castro, JL ;
Shearman, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (48) :45394-45402
[4]   In vivo calpain/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration -: Implication of a calpain-mediated cleavage of active caspase-3 [J].
Bizat, N ;
Hermel, JM ;
Humbert, S ;
Jacquard, C ;
Créminon, C ;
Escartin, C ;
Saudou, F ;
Krajewski, S ;
Hantraye, P ;
Brouillet, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :43245-43253
[5]   Presenilins: Multifunctional proteins involved in Alzheimer's disease pathology [J].
Checler, F .
IUBMB LIFE, 1999, 48 (01) :33-39
[6]  
CHECLER F, 1995, J NEUROCHEM, V65, P1431
[7]   The multiple paradoxes of presenilins [J].
Checler, F .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (06) :1621-1627
[8]  
Citron Martin, 2001, Expert Opin Ther Targets, V5, P341, DOI 10.1517/14728222.5.3.341
[9]   Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons [J].
da Costa, CA ;
Paitel, E ;
Mattson, MP ;
Amson, R ;
Telerman, A ;
Ancolio, K ;
Checler, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :4043-4048
[10]   A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain [J].
De Strooper, B ;
Annaert, W ;
Cupers, P ;
Saftig, P ;
Craessaerts, K ;
Mumm, JS ;
Schroeter, EH ;
Schrijvers, V ;
Wolfe, MS ;
Ray, WJ ;
Goate, A ;
Kopan, R .
NATURE, 1999, 398 (6727) :518-522